LP99633-7
Paliperidone
Deprecated
Description
Paliperidone (sold as INVEGA, INVEGA Sustenna) is an atypical antipsychotic developed by Janssen Pharmaceutica. Invega is an extended release formulation of paliperidone that uses the OROS extended release system to allow for once-daily dosing. Invega Sustenna (paliperidone palmitate) is a long-acting injectable formulation of paliperidone indicated for once-monthly injection after an initial titration period. Chemically, paliperidone is the primary active metabolite of the older atypical antipsychotic risperidone (paliperidone is 9-hydroxyrisperidone, i.e. risperidone with an extra hydroxyl group). It is indicated for the acute and maintenance treatment of schizophrenia. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Paliperidone
Basic Part Properties
- Part Name
- Paliperidone
- Part Display Name
- Paliperidone
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2010-03-08
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-ES | Spanish (Spain) | Paliperidona |
| it-IT | Italian (Italy) | Paliperidone Synonyms: parte ritirata |
| tr-TR | Turkish (Turkey) | Paliperidon |
| nl-NL | Dutch (Netherlands) | paliperidon |
| fr-BE | French (Belgium) | Palipéridone |
| zh-CN | Chinese (China) | 帕潘立酮 Synonyms: 9-羟基利培酮; |
| pl-PL | Polish (Poland) | Paliperydon |
| el-GR | Greek (Greece) | Παλιπεριδόνη Synonyms: Παλιπεριδόνη |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://